Anti-Ochratoxin A antibody (HRP) (ab111040)
- Product nameAnti-Ochratoxin A antibody (HRP)See all Ochratoxin A primary antibodies ...
- DescriptionRabbit polyclonal to Ochratoxin A (HRP)
- Conjugation notesOA-NHS active ester, via acylation reaction. Ochratoxin A/HRP molar ratio, approximately 3:1.
- Tested applicationsCompetitive ELISA more details
The immunogen is prepared by NHS-activated Ochraotxin A via its carboxyl group coupled to KLH
- Storage instructionsShipped at 4°C. Store at -20ºC.
- Storage bufferConstituents: PBS, 50% Glycerol
- Concentration information loading...
- PurityImmunogen affinity purified
- Clonality Polyclonal
- Research Areas
Our Abpromise guarantee covers the use of ab111040 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|Competitive ELISA||cELISA: Use at an assay dependent dilution.|
- RelevanceOchratoxin A is a polyketide-derived dihydroiso-coumarin moiety linked through the 12-carboxy group to phenylalanine. Ochratoxin A is the most important and most commonly occurring of a structurally related group of compounds. It is produced by some species of Aspergillus, such as A. ochraceus, mainly in tropical regions, and by Penicillium verrucosum, a common storage fungus in temperate areas such as Canada, eastern and north western Europe and parts of South America. Ochratoxin A is a potent toxin affecting mainly the kidneys, in which it can cause both acute and chronic lesions, whereas its dechloro derivative, ochratoxin B, is non-toxic. A nephrotoxic effect has been demonstrated in all mammalian species.
- Cellular localizationSecreted
Anti-Ochratoxin A antibody (HRP) images
Direct competitive inhibition ELISA using immobilized ab111040 at 1.5 ug/ml, and OA-labeled HRP (50 ng/mL). 50% inhibition occurred at 25 ng/mL of free Ochratoxin A in non-optimized conditions.
References for Anti-Ochratoxin A antibody (HRP) (ab111040)
ab111040 has not yet been referenced specifically in any publications.